Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
The Journal of Urology
|
April 1, 2021
Utility of Routine Preoperative <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy. Reply
S Dason, N C Wong, T F Donahue, et al.
ESMO Open
|
June 6, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
M Sternschuss, N Toumbacaris, J P Das, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2025
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
R S Matulewicz, F Baky, N Liso, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
M D Galsky, J E Gschwend, M I Milowsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Y Fradet, J Bellmunt, D J Vaughn, et al.
Urologic Oncology
|
June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."
M Y Teo, R M Bambury, E C Zabor, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
The Journal of Urology
|
April 1, 2021
Utility of Routine Preoperative <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy. Reply
S Dason, N C Wong, T F Donahue, et al.
ESMO Open
|
June 6, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
M Sternschuss, N Toumbacaris, J P Das, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2025
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
R S Matulewicz, F Baky, N Liso, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
M D Galsky, J E Gschwend, M I Milowsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Y Fradet, J Bellmunt, D J Vaughn, et al.
Urologic Oncology
|
June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."
M Y Teo, R M Bambury, E C Zabor, et al.
Page
of 10